Dhaka, Oct. 18 -- Experts from leading health institutions gathered at icddr,b, for a Roundtable Discussion on introducing higher-valency pneumococcal conjugate vaccines (PCVs) in Bangladesh. The dialogue focused on optimising vaccine-induced protection against circulating pneumococcal serotype and addressing the emerging challenge of serotype replacement.

The session followed a pneumococcal surveillance study jointly conducted by icddr,b and the Institute of Epidemiology, Disease Control and Research (IEDCR), with support from the US Centers for Disease Control and Prevention (CDC). The study, presented by Dr Md Zakiul Hassan, Associate Scientist at icddr,b's Infectious Diseases Division and Principal Investigator, analysed data from fo...